Needham & Company LLC Reiterates Buy Rating for Revolution Medicines (NASDAQ:RVMD)
Needham & Company LLC reiterated their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Tuesday,Benzinga reports. The brokerage currently has a $59.00 price objective on the stock. Several other equities analysts have also weighed in on RVMD. Wedbush reissued an “outperform” rating and set a $67.00 […]
Needham & Company LLC reiterated their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Tuesday,Benzinga reports. The brokerage currently has a $59.00 price objective on the stock. Several other equities analysts have also weighed in on RVMD. Wedbush reissued an “outperform” rating and set a $67.00 […]